These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26724334)

  • 1. Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological context.
    Vauquelin G; Van Liefde I; Swinney DC
    Drug Discov Today Technol; 2015 Oct; 17():28-34. PubMed ID: 26724334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic binding assays for the analysis of protein-ligand interactions.
    Meyer-Almes FJ
    Drug Discov Today Technol; 2015 Oct; 17():1-8. PubMed ID: 26724330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.
    Vauquelin G; Charlton SJ
    Br J Pharmacol; 2010 Oct; 161(3):488-508. PubMed ID: 20880390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioligand-binding methods for membrane preparations and intact cells.
    Bylund DB; Deupree JD; Toews ML
    Methods Mol Biol; 2004; 259():1-28. PubMed ID: 15250483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems.
    Vauquelin G; Van Liefde I
    Expert Opin Drug Discov; 2012 Jul; 7(7):583-95. PubMed ID: 22650795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action.
    Vauquelin G
    Expert Opin Drug Discov; 2015 Oct; 10(10):1085-98. PubMed ID: 26165720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioligand binding methods for membrane preparations and intact cells.
    Bylund DB; Toews ML
    Methods Mol Biol; 2011; 746():135-64. PubMed ID: 21607856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioligand binding methods: practical guide and tips.
    Bylund DB; Toews ML
    Am J Physiol; 1993 Nov; 265(5 Pt 1):L421-9. PubMed ID: 8238529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-receptor interaction platforms and their applications for drug discovery.
    Fang Y
    Expert Opin Drug Discov; 2012 Oct; 7(10):969-88. PubMed ID: 22860803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the use of cells or membranes for receptor binding: growth hormone secretagogues.
    Pinyot A; Nikolovski Z; Bosch J; Segura J; Gutiérrez-Gallego R
    Anal Biochem; 2010 Apr; 399(2):174-81. PubMed ID: 20060802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays.
    Zhu Z; Kim S; Chen T; Lin JH; Bell A; Bryson J; Dubaquie Y; Yan N; Yanchunas J; Xie D; Stoffel R; Sinz M; Dickinson K
    J Biomol Screen; 2004 Sep; 9(6):533-40. PubMed ID: 15452340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand.
    Berry J; Price-Jones M; Killian B
    Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoactive assemblies of organic compounds and biomolecules: drug-protein supramolecular systems.
    Vayá I; Lhiaubet-Vallet V; Jiménez MC; Miranda MA
    Chem Soc Rev; 2014 Jun; 43(12):4102-22. PubMed ID: 24637992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics.
    Nagar S; Korzekwa K
    Drug Metab Dispos; 2012 Sep; 40(9):1649-52. PubMed ID: 22711748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
    Turner JT; Bylund DB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):873-81. PubMed ID: 2821229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.
    Martinez Molina D; Jafari R; Ignatushchenko M; Seki T; Larsson EA; Dan C; Sreekumar L; Cao Y; Nordlund P
    Science; 2013 Jul; 341(6141):84-7. PubMed ID: 23828940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting drug promiscuity using Gaussian ensemble screening.
    Pérez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
    J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.